Central Venous Catheter Colonisation Among Critically Ill Patients in Intensive Care Units

Sponsor
Makerere University (Other)
Overall Status
Completed
CT.gov ID
NCT03270774
Collaborator
(none)
100
12

Study Details

Study Description

Brief Summary

Background: Central Venous catheter insertion technique and indwelling time are major risk factors for CVC colonisation. Colonisation occurs through microbial migration and biofilm formation along the catheter insertion tract. This study set out to determine the prevalence and associated factors for central venous catheter colonisation among critically ill patient. No data exists in this clinical setting addressing this topic.

Methods: The study population included 100 participants with central venous catheters in situ for at least 24 hours. Catheter tip (distal 5-cm segment) and blood cultures (10mls peripheral blood) were obtained at the time of catheter removal.

Detailed Description

Introduction : Central venous catheter (CVC) insertion technique and time spent in situ (dwell period) are major risk factors for CVC colonisation among patients admitted to intensive care units (ICU) worldwide. Normal skin flora colonizes CVCs early in their dwell period (< 7-10 days) causing variable occurrence of infections in all categories of patients. Uganda has no data on CVC colonisation and with increasing use there is concern of CVC colonisation and its consequences. This study was done to determine the prevalence and associated factors of CVC colonization among patients in general ICUs.

Methodology: This was prospective cohort study. Critically ill patients with CVCs in situ from four general ICUs were consecutively enrolled into the study. Data on socio-demographic, clinical characteristics (diagnosis, comorbidities) and CVC insertion (site, technique, experience) was collected using a standardised questionnaire until a sample size of 100 was achieved. At the time of CVC removal, the CVC tip (distal 5cm segment) was aseptically obtained and cultured for microorganisms using the semi-quantitative method. A blood culture sample (10mls) was also collected from a peripheral site at the same time. Data was double entered into EPIDATA version 3.1.5 and exported to STATA version 12.0 for analysis.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Central Venous Catheter Colonisation: Prevalence and Associated Factors Among Critically Ill Patients Admitted to Ugandan Intensive Care Units
Actual Study Start Date :
Apr 19, 2016
Actual Primary Completion Date :
Apr 10, 2017
Actual Study Completion Date :
Apr 19, 2017

Outcome Measures

Primary Outcome Measures

  1. Prevalence of central venous catheter colonisation [up to 14 days]

    Of the patients that had central venous catheter inserted, how many of them developed central venous catheter colonisation

Secondary Outcome Measures

  1. Prevalence of Central venous catheter associated bloodstream infections [Up to 48 hours after removal of central venous catheter]

    Of the patients that developed central venous catheter colonisation, how many of them developed associated bloodstream infection

  2. Factors associated with central venous catheter colonisation [up to 14 days]

    Factors that have a significant p-value < 0.5 of association with central venous catheter colonisation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients of all age groups were included in this study

  • All critically ill patients admitted to the ICU with Central Venous Catheters in situ

  • Written informed consent/assent

  • Waiver of consent for unconscious patients with no attendant/valid surrogate respondent to provide the required information

Exclusion Criteria:

•Patients who were already on treatment for CVC-related infectious complications.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Makerere University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Makerere University
ClinicalTrials.gov Identifier:
NCT03270774
Other Study ID Numbers:
  • CVC Study
First Posted:
Sep 1, 2017
Last Update Posted:
Sep 1, 2017
Last Verified:
Aug 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2017